The purpose of this study is to determine how many children with and without known COVID-19 infections have made an immune response (blood antibodies) over time. We will also do more extensive testing of the immune system on a smaller group of children.
AB3C Study in the news
View AB3C related news articles
This study has been approved by the University of Calgary's Conjoint Health Research Ethics Board (CHREB). Ethics ID: REB20-0480
Cette étude a été approuvée par le Comité conjoint d'éthique de la recherche en santé de l'Université de Calgary, Ethics ID: REB20-0480
The AB3C study is supported by Alberta Health Services (AHS), Alberta Precision Laboratories-Public Health, the University of Calgary, and the Alberta Children’s Hospital, and is funded by Genome Alberta, Alberta Health, and the Alberta Children’s Hospital Foundation through the Alberta Children's Hospital Research Institute (ACHRI).